GlassScriptPhysician profile
Natalie Wong
NPI 1578812608
$5,312.58
in general payments reported to CMS, 2019-2025
32 companies · $792 in 2025
The $792 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $893 · 2020: $98.99 · 2021: $265 · 2022: $613 · 2023: $1,940 · 2024: $712 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,859 · Travel and Lodging: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,858.95 |
| Travel and Lodging | $1,584.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,030.66 | 2023 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $755.36 | 2022-2025 | Ztlido |
| Boston Scientific Corporation | $682.16 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $569.94 | 2023 | Iovera, Exparel, Zilretta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $536.39 | 2022-2025 | Relistor |
| Horizon Therapeutics Plc | $262.78 | 2020-2022 | |
| Medtronic USA, INC. | $178.50 | 2019 | |
| Collegium Pharmaceutical, INC. | $178.33 | 2021-2025 | Belbuca |
| Globus Medical, INC. | $142.54 | 2025 | Senza |
| Si-Bone, INC. | $108.68 | 2023-2024 | |
| Redhill Biopharma INC. | $95.34 | 2020-2021 | |
| Medtronic, INC. | $92.07 | 2021-2025 | Accurian, Intellis Adaptivestim |
| Vertos Medical, INC. | $82.97 | 2024 | Mild Device Kit |
| Valinor Pharma, LLC | $61.72 | 2023-2025 | Movantik |
| Pfizer INC. | $59.72 | 2020-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $55.84 | 2020-2022 | |
| Abbott Laboratories | $53.26 | 2019 | |
| Ibsa Pharma INC. | $43.39 | 2022-2024 | Tirosint, Licart, Tirosint |
| Avanos Medical | $36.14 | 2022-2023 | Genvisc 850 Sodium Hyaluronate |
| Azurity Pharmaceuticals, INC. | $34.96 | 2023-2024 | Horizant, Horizant |
| International Rehabilitative Sciences, INC | $31.70 | 2023 | Rs 4i Plus Sequential Stimulator |
| Protega Pharmaceutials INC | $28.77 | 2024 | Roxybond |
| Almatica Pharma LLC | $27.46 | 2022 | |
| Foundation Fusion Solutions, LLC | $23.74 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.18 | 2025 | |
| Convatec INC. | $19.16 | 2024 | |
| Forte Bio-Pharma LLC | $18.78 | 2025 | Prolate, Tanlor, Nalocet |
| Biotronik Nro, INC. | $18.11 | 2025 | Prospera |
| Spr Therapeutics, INC | $17.52 | 2024 | Sprint Pns System |
| Sanofi-Aventis U.S. LLC | $17.43 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $16.36 | 2023 | Seglentis |
| Amgen INC. | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.